Human Milk Oligosaccharides (HMO) Workshop
Chairman David Mills University of California, USA
  Human Milk Oligosaccharides and Their Role in Shaping the Infant Intestinal Microbiota
14.30 Koen Venema Maastricht University, The Netherlands
  Fermentation of 13C-labeled 6’-sialyl Lactose by Microbiotas Originating from Babies, Adults and Elderly – Tracing the Label
15.15 Norbert Sprenger Nestlé Research Center, Switzerland
  Human Milk Oligosaccharides (HMOs) Biology, Lessons from Preclinical Models
16.00 coffee break  
16.30 Wim Soetaert Inbiose - Speciality Carbohydrates, Belgium
  Efficient Synthesis of Specialty Carbohydrates and Human Milk Oligosaccharides Through Industrial Biotechnology
17.15 Gert Folkerts - Liao Xing Utrecht University, the Netherlands
  Early Supplementation of Human Milk Oligosaccharides Suppresses Spontaneous Autoimmune Diabetes in Non-obese Diabetic Mice Later in Life
Nutrition and Health Claims - Regulatory - Workshop
13.00 Elinor McCartney Pen & Tec Consulting, Spain
  Regulation of Probiotics in the EU - What’s New?  
16.30 coffee break  
17.00 TBD European Food Safety Authority - EFSA
Pediatric Nutrition
Plenary Speaker Hania Szajewska Medical University of Warsaw, Poland
Probiotics in Children - Do They Work? A critical review of the pediatric use of probiotics from a practitioner´s point of view
09.50 Erica Eliana Castro Universidad San Sebastián, Chile
  Design of Orally Administered Probiotic Formulation for the Prevention of Obesity in Children  
10.05 Myriam Coulet Nestlé Research Center, Switzerland
  Establishment of the Safety in Use of Two Synthetic Human Milk, Nature-Identical, Oligosaccharides 2’-O-Fucosyllactose (2’FL) and Lacto-N-Neotetraose (LNnT) for Infant Formula
10.20 Liubov Shynkarenko Sichel Pure Research Products, USA
  Clinical Efficacy of Probiotic Lysate Del-ImmuneV® for the Treatment of Gastrointestinal Manifestations Assocciated With Food Allergy in Preschool Children
10.40 coffee break  
Gut Barrier Function and Microbial Metabolism
11.00 Jerry Wells Wageningen UR, the Netherlands
Chairman Human Intestinal Barrier Function in Health & Disease
11.15 Clara Garcia Rodenas Nestlé Research Center, Switzerland
  Health Benefits of Probiotics by Impacting Intestinal Barrier Function  
11.30 Jonathan Swann Imperial College London, UK
  Influence of gut microbial metabolism on the biochemical profile of dietary compounds  
11.45 Kieran Tuohy Fondazione Edmund Mach-IASMA, Italy
  Toward Microbial Fermentation Metabolites as Markers for Health Benefits of Prebiotics  
12.00 Bob Rastall University of Reading, U
Keynote Prebiotic Manipulation of the Human Gut Microbiome for Health  
12.40 lunch break  
13.40 Johan Garssen Danone/Nutricia Research, the Netherlands
Invited Speaker Regulatory T-Cell Depletion Abolishes the Protective Effect of Dietary Galacto-Oligosaccharides on Eosinophilic Airway Inflammation in House Dust Mite-Induced Asthma
13.55 Manuela Sailer BENEO-Institute, Germany
  Snapshots on Recent Prebiotic Fiber Research  
14.10 Emanuela Simonetti Kamut Enterprises of Europe, Italy
  Prebiotic Potential of KAMUT® Khorasan Wheat: From in Vitro Studies to Human Clinical Trials  
14.25 Monika Müller University of Vienna, Austria
  Effect of Fructans with Different Degree of Polymerization and Structure on Growth of Selected Probiotic Strains and Formation of Short Chain Fatty Acids
14.40 Quiao Shi University of Helsinki, Finland
  Synthesis of Prebiotic Isomaltooligosaccharides by Weissella Confusa Dextransucrase  
14.55 Massalin Nakphaichit (YSA) Kasetsart University, Thailand
  Potential Use of Lactococcus Lactis KA-FF 1-4 Supplement with Non-digestible Oligosaccharide Against Vancomycin-resistant Enterococci
Modulation of the Intestinal Micro-flora
15.05 Gert Folkerts Utrecht University, the Netherlands
Invited Speaker Microbiome Manipulation and Immune Regulation: Impact for Non Communicable Diseases?  
15.15 Hyunjoon Park (YSA) Handong Global University, South Korea
  Autoinducer-2 Signalling in Probiotics: A Mechanism of Gut Microbiota Modulation  
15.25 Anna Maria Szyc (YSA) Institute of Animal Reproduction and Food Research of PAS
  Impact of L.bulgaricus-151 Fermented Buttermilk on Intestinal Microbiota Composition of Allergic and Non-allergic Mice Model
15.35 Mercè Hereu (YSA) Institute of Advanced Chemistry of Catalonia, Spain
  Prebiotic-like Effect of D-fagomine in Gut Microbiota  
15.45 Pieter Van den Abbeele (YSA) ProDigest, Belgium
  Use of Microbial Networks as a Strategy to Recover From Gut Dysbiosis  
15.55 cofee break  
Targeted Modulation of Gut Microbiota, its Transplantation and Probiotics
16.15 Alojz Bomba Institute of Experimental Medicine, Slovakia
Chairman Targeted Modulation of Gut Microbiota in Chronic Disease Prevention and Therapy  
16.30 Monika Fischer Indiana University, USA
Invited Speaker Fecal Microbiota Transplantation in Gastrointestinal Diseases: 2016 Update and the Road Ahead  
16.45 Susan A Joyce APC Microbiome Institute, Ireland
  Bile Alt Metabolism in the Gut : Lessons From the Microbiota  
17.00 Tarkan Karakan Gazi University, Turkey
  Obstacles in FMT: Methodology or donor properties?  
17.30 Networking Bar, Poster Visit and Welcome Drink  
Wednesday 9:00 - 18:00
Human Milk Oligosaccharides
9.00 David A. Mills University of California, USA
Plenary Speaker Establishment of a Milk-oriented Microbiota in Infants: New Insight into Probiotics and Prebiotics
9.50 Norbert Sprenger Nestlé Research Center, Switzerland
Keynote Speaker Human Milk Oligosaccharides (HMOs): From Observation to Clinical Intervention
10.30 Wim Soetaert Inbiose - Speciality Carbohydrates, Belgium
  Efficient Synthesis of Specialty Carbohydrates and Human Milk Oligosaccharides Through Industrial Biotechnology
10.45 coffee break  
Clinical Trials and Health Claim Substantiation
11.05 Yasuhiro Koga Tokai University School of Medicine, Japan
Invited Speaker Functional Dyspepsia: A Novel Field for the Introduction of Gastric Probiotics  
11.20 Markus Lehtinen DuPont Nutrition and Health, Finland
  Bifidobacterium Animalis Ssp. Lactis 420 With or Without Litesse®Ultra Controls Body Fat Mass and Waist Circumference in Overweight and Obesity – Randomized, Double-Blind, Multicenter Clinical Study
11.35 Junichi Minami Morinaga Milk Industry, Japan
  Effects of Bifidobacterium Supplementation on Mild Anemia Women in a Randomized Controlled Trial
11.50 Christiane Laue Clinical Research Center, Germany
  Immunomodulatory effects of non-digestible polysaccharides – a double-blind, randomized, controlled clinical trial
Microbiome of the GIT
12.05 Kathleen McCoy University of Bern
Keynote Speaker The Role of Gut Microbiota in Immune Development and Homeostasis  
12.45 Sara Ramos-Romero Institute of Advanced Chemistry of Catalonia, Spain
  Changes in Gut Microbiota Subgroups Differently Relate to Progression of Obesity, Hypertension and Insulin Resistance in Rats
13.00 lunch break  
14.00 Eric Guillemard Danone/Nutricia Research, the Netherlands
  Probiotics and Respiratory Tract Infections: What’s New?  
14.15 Linda Mulder Winclove Probiotics, the Netherlands
  Microbiota Managment for the Prevention of Recurrent Ear and Throat Infections  
Models to Study Intestinal Interactions
14.30 Michiel Kleerebezem Wageningen UR, the Netherlands
Keynote Speaker Small Intestine Microbiology and Probiotic Modes of Action  
15.10 Gwénaël JAN INRA, France
Invited Speaker The Probiotic Propionibacterium Freudenreichii as a New Adjuvant for TRAIL-Based Therapy in Colorectal Cancer
15.25 Wilhelm H Holzapfel Handong Global University, South Korea
Invited Speaker Using a Diet-induced Obesity Murine Model for Studying Active and Whole Microbial Communities and Their Probiotic Modulation
15.40 Poonam Singh (YSA) Universidade de Coimbra, Portugal
  Characterization of Cellulose Based Hydrogels as Probiotics Delivery Vehicles  
15.50 Jos van der Vossen TNO, the Netherlands
  Intestinal Microbiota Screening Platform (I-Screen) Provides Insights Into the Effects of Food Ingredients and Medication on Gut Microbiota Composition and - Activity
16.05 Sae Hun Kim Korea University, South Korea
  Probiotics Modulate the Gut-bone-microbiota Axis in Ovariectomized Murine Model  
16.20 coffee break  
Delivery Vehicles
16.40 Katja Krizman (YSA) National University of Singapore, Singapore
  Growth and Fermentative Activities of Probiotic Starter Culture Treated With High Intensity Ultrasound in Mono- and Co-Culture
16.50 Fernanda B. Haffner CNRS-Université de Lorraine, France
  Encapsulation of L. rhamnosus GG (LGG) in Alginate-Silicate Hybrid Beads  
17.05 Song Huang (YSA) STLO, Agrocampus Ouest, INRA, France
  Major Breakthrough in Probiotic Production: The Two-in-One Use of Sweet Whey Affords Yet Unknown Probiotic Viability and Stability
Mechanisms of Action
17.15 Sin-Hyeog Im Institute for Basic Science (IBS) and POSTECH, South Korea
Chairman Probiotics for Hyper-immune Disorders: Selection and Mode-of-action  
17.30 Nicolas Szita University College London, UK
  Real-Time Monitoring of Specific Oxygen Uptake Rates of Adherent Cells in a Microfluidic Device  
17.45 Tsuguhito Ota Kanazawa University, Japan
  Lactobacillus Pentosus Strain S-PT84 Attenuates Lipotoxicity-Induced Hepatic Insulin Resistance and Steatohepatitis by Maintaining Gut Permeability and Inducing Macrophage Alternative Activation in Mice
17.55 Soyoung Park (YSA) Handong Global University, South Korea
  Study on the Functionality of Two Different Lactobacillus Rhamnosus Strains in a Murine Model  
20:00 Conference Dinner  
Paralel Sessions on Wednesday
Bacteriocins and Antimicrobial Peptides
14.00 Svetoslav Todorov Universidade Federal de Viçosa, Brazil
Chairman Bacteriocins - Answer to Increasing Problem of Antibiotic Resistance?  
14.20 Dzung Diep Universiteit for Miljoog Biovitenskap, Norway
  A Breakthrough in Identification of Bacteriocin Targets  
14.40 Corli Witthuhn University of the Free State, Republic of South Africa
  Control of Tuberculosis Using Bacteriocinogenic LAB  
15.00 Hilário C. Mantovani Universidade Federal de Viçosa, Brazil
  Diversity and Activity of Lantibiotics Produced by Ruminal Streptococci  
15.20 Baljeet Singh Saharan Kurukshetra University, India
  Bacteriocins From LAB  
16.00 coffee break  
Paralel Sessions on Wednesday
Animal Helath Session
16.20 Ajay Awati DuPont Industrial Biosciences, UK
Chairman Feed Enzymes, Prebiosis, and Gut Health: a Vital Part in Feed Additive Strategy in Post-anti Microbial Growth Promoter Era
16.40 Gholamreza Salehi Jouzani Agricultural Biotechnology Research Institute of Iran
  Designing Specific and Efficient Probiotics for Broiler Chickens Based on Native Lactobacillus Strains  
17.00 Karoline Sidelmann Brinch Novozymes, Denmark
  Novel Bacillus Subtilis Strain Brings Health Benefits and Improvement of Performance in Broilers  
17.20 Ramona Cernat Chr Hansen A/S, Denmark
  New Probiotic Bacillus spp. Improves Gut Health in Piglets  
17.40 Brian B Oakley Western University of Health Sciences, USA
  Research and Development for an Effective Avian Probiotic  
Mechanisms of Action
09.00 Lyudmila Lazarenko Zabolotny Institute of Microbiology and Virology, Ukraine
  Probiotic Strains Alter the Cytokines Production at Monosodium Glutamate-Induced Obesity in Rats  
09.15 Mia Christine Theilmann (YSA) Technical University of Denmark, Denmark
  An ATP-Binding Cassette (ABC) Uptake System Governs the Preference of Probiotic Bifidobacterium Animalis Subsp. Lactis for β-Galactosides
09.25 Kohei Kamikado (YSA) Ezaki Glico Co., Japan
  Effect of Bifidobacterium Animalis Ssp. Lactis GCL2505, a Probiotic Strain That Proliferates in the Gut, on Visceral Fat Accumulation: Evidence From Human and Mice Studies
09.35 Cristian Botta (YSA) University of Turin, Italy
  Comparative Genomics and Functional Analysis of Lactobacillus Plantarum Probiotic Candidates Highlighted a Strain-Dependent Capability to Produce Butyric Acid by Fatty Acid Biosynthesis Pathway
09.45 Vincenzo Cesi ENEA, Italy
  Omega 3, L. Reuteri and Vitamin D Collaborate in Diminishing Gut Inflammation  
10.00 Priti Mudgil (YSA) United Arab Emirates University, UAE
  Pancreatic Lipase Inhibitory Activities of Lactic Acid Bacteria Isolated From Raw Camel Milk  
10.10 Sejong Oh Chonnam National University, South Korea
  The Doubts and Truths of Plant-Origin Probiotics: Is It Really More Beneficial to Human Health Than Human (Animal)-Origin?
10.25 coffee break  
What’s in a name? Round table considerations about probiotics, pharmabiotics, probioceuticals…
10.45 Bruno Pot - Chair Institut Pasteur de Lille, France
  Sin-Hyeog IM Institute for Basic Science (IBS) and POSTECH, South Korea
  Prof Henk van Loveren European Food Safety Authority - EFSA
  Carine Lambert International Probiotics Association - IPA Europe
  Magali Cordaillat-Simmons Pharmabiotic Research Institute, France
  David Mills University of California, USA
Regulatory Issues and Barriers
11.30 Elinor McCartney Pen & Tec Consulting, Spain
Chairman Regulation of Probiotics in the EU - What’s New?  
12.10 Henk van Loveren European Food Safety Authority - EFSA
Keynote speaker EFSA - TBD  
12.55 lunch break  
Novel Strains and Approaches
14.00 Sarah Lebeer Uantwerpen, Belgium
Invited Speaker Lactobacilli as Alternative for Antibiotics in Non-Intestinal Applications  
14.40 Ales Berlec Jozef Stefan Institute, Slovenia
  Engineering Lactic Acid Bacteria With Cytokine/Chemokine Binding Ability and Infrared Fluorescence for Imaging-Guided Treatment of Inflammatory Bowel Disease
Future of Probiotics and Prebiotics – Visions and Opportunities
14.55 Tadao Saito Graduate School of Agricultural Sciences, Japan
Keynote Speaker Development of New Functional Yogurts Using Probiotics Lactic Acid Bacteria (LAB) and/or Bifidobacteria and the Future Strategy in Japan
15.35 Harsh Panwar (YSA) Guru Angad Dev Veterinary and Animal Sciences University, India
  Probiotic Stimulation of Incretin Hormone Secretion as a Potential Therapeutic Strategy for Type 2 Diabetes Mellitus: Examining the Mechanism of Action
15.45 Cristina Barrera Universitat Politècnica de València, Spain
  Improving the Probiotic Effect of Lactobacillus Salivarius Spp. Salivarius in Mandarin Juice by Adding Trehalose and/or Applying High Pressure Homogenization
16.00 Ying-Chieh Tsai National Yang-Ming University, Taiwan
  Microbiota-Gut-Brain Axis and Psychobiotics: Lactobacillus Plantarum PS128 as an Example
16.15 Sam Possemiers ProDigest, Belgium
  Use of Microorganisms for Carotenoids Delivery: Next Generation of Probiotics for Cardiovascular Disease
16.30 Young Scientist Awards and Best Poster Awards ceremony


16.45 Farewell Drink  
END of the conference

International Scientific Conference on probiotics and Prebiotics IPC2016 Programme Program